Latest Update — As of September 8, 2026: The picture on this page has changed since it was last published. On June 4, 2026, Merck agreed to settle more than 200 Gardasil lawsuits for a total of roughly $50 million, without admitting liability. The deal resolves the bulk of the federal MDL along with a closely watched California state case (Jennifer Robi) that had been headed to a jury trial. Merck has said the settlement addresses all but one of its remaining Gardasil cases. This is a major shift from the “no global settlement yet” and “bellwether trials pending” status described below — most of that active litigation phase is now over.
Last updated: September 2026
The Gardasil lawsuit is one of the largest active pharmaceutical litigations in the United States right now. Thousands of people who received the HPV vaccine have filed claims against Merck, alleging the company hid serious risks and caused permanent injuries.
As of 2026, over 1,400 cases are consolidated inside a federal multidistrict litigation in North Carolina. Bellwether trials are now shaping how much money individual plaintiffs may recover.
This article breaks down everything you need to know. From who qualifies to what the payout ranges look like to how to actually file a claim before the deadline.
One fact that surprises most people: Gardasil generates over $2 billion in annual revenue for Merck. Yet the company faces mounting evidence it downplayed serious neurological and autoimmune risks in its clinical trials.
What Is the Gardasil Lawsuit?
The Gardasil lawsuit is a mass tort litigation filed against Merck, the maker of the Gardasil HPV vaccine, by individuals who say the vaccine caused serious, life-altering injuries.
These lawsuits are not a class action. Each plaintiff has an individual claim based on their specific injury, medical history, and circumstances. The cases are joined together for pretrial coordination in a multidistrict litigation, which is a federal process designed to handle large volumes of similar lawsuits efficiently.
The central allegations are serious. Plaintiffs claim Merck knew about potential risks, including debilitating neurological disorders, autoimmune conditions, and reproductive damage, but failed to adequately warn doctors or patients. They also argue the clinical trial data was manipulated to obscure safety signals.
The litigation officially became MDL No. 3036, titled “In re: Gardasil Products Liability Litigation.” It is being heard in the U.S. District Court for the Western District of North Carolina before Judge Robert Conrad.
| MDL Detail | Information |
|---|---|
| MDL Number | MDL No. 3036 |
| Court | U.S. District Court, W.D. North Carolina |
| Presiding Judge | Judge Robert Conrad |
| Cases Filed (as of 2026) | 1,400+ active plaintiffs |
| Defendant | Merck and Co. Inc. |
| Vaccine at Issue | Gardasil and Gardasil 9 |
The vaccine was first approved by the FDA in 2006. Gardasil 9, an updated version covering more HPV strains, was approved in 2014. Both versions are named in the lawsuits.
What Is the Gardasil Lawsuit Payout Range?
No official settlement has been announced yet, but legal analysts and attorneys following the MDL project individual payouts could range from $250,000 to over $1 million depending on injury severity.
That wide range exists because mass tort litigation does not pay everyone equally. Payouts are typically tiered based on how severe and permanent the injury is, how old the plaintiff was when injured, and whether they can prove a direct link between the vaccine and their condition.
Think of it like an insurance claim after a car accident. Two people can be in the same crash, but one walks away with a bruise and one has spinal damage. The payouts reflect that difference.
Plaintiffs with conditions like POTS or CRPS that have rendered them unable to work, attend school, or live a normal life are expected to receive the highest tier compensation. Milder cases with documented but less severe outcomes may fall on the lower end.
| Injury Severity | Projected Payout Range |
|---|---|
| Severe, permanent disability (e.g., CRPS, full POTS) | $500,000 to $1,000,000+ |
| Moderate injury with ongoing treatment | $150,000 to $500,000 |
| Documented injury, partial recovery | $50,000 to $150,000 |
| Minor documented adverse reaction | $10,000 to $50,000 |
These figures are projections based on comparable pharmaceutical mass tort outcomes. Final amounts will depend on bellwether trial verdicts and any global settlement Merck agrees to negotiate.
How Much Is the Gardasil Lawsuit Settlement Amount?
There is no confirmed global settlement amount yet for the Gardasil lawsuit as of early 2026. The case is still in pretrial and bellwether trial phases before any large-scale settlement is reached.
This is normal for mass tort litigation. Most major pharmaceutical cases follow the same pattern: trials happen first, verdicts come in, both sides get a realistic picture of their exposure, and then a global settlement is negotiated.
For reference, the Roundup (glyphosate) litigation saw Bayer agree to pay over $10 billion to settle roughly 125,000 claims. The Talcum powder lawsuits against Johnson and Johnson ran into the tens of billions as well. These comparisons are useful context for understanding the scale Merck may eventually face.
Legal experts watching the Gardasil MDL have noted that if even one or two early bellwether trials result in large plaintiff verdicts, Merck will face enormous pressure to settle the remaining docket globally.
Key figure: Legal analysts have placed Merck’s potential total settlement exposure at anywhere from $800 million to over $3 billion if the litigation reaches full resolution.
| Settlement Comparison | Case | Total Payout |
|---|---|---|
| Roundup Herbicide | Bayer | $10.9 Billion |
| Talcum Powder | Johnson and Johnson | $8.9 Billion (proposed) |
| Zofran Birth Defects | GlaxoSmithKline | $1.1 Billion |
| Vioxx Cardiovascular | Merck | $4.85 Billion |
| Gardasil (projected) | Merck | $800M to $3B+ (est.) |
Who Qualifies for the Gardasil Lawsuit?
You may qualify for the Gardasil lawsuit if you received the Gardasil or Gardasil 9 vaccine and subsequently developed a serious medical condition that was not adequately disclosed as a risk.
Eligibility is not automatic just because you received the vaccine. Attorneys and courts look for a clear connection between the vaccination and the injury, typically supported by medical records.
The strongest cases involve plaintiffs who:
- Received Gardasil or Gardasil 9 between 2006 and the present
- Developed a qualifying condition within a reasonable timeframe after vaccination
- Have medical documentation of the diagnosis
- Were not already diagnosed with the condition before vaccination
- Received the vaccine in the United States
Age matters too. Most plaintiffs were between 9 and 26 years old when vaccinated, which was the recommended age range at the time of their shots.
| Eligibility Factor | Details |
|---|---|
| Vaccine Received | Gardasil or Gardasil 9 |
| Vaccination Period | 2006 to present |
| Age at Vaccination | 9 to 26 (typical recommended range) |
| Required Documentation | Medical records, diagnosis, vaccination records |
| Primary Conditions | POTS, CRPS, POI, autoimmune disorders |
| Location | United States vaccinations only |
If you are unsure whether your condition qualifies, the sections below on POTS, CRPS, and vaccine injury symptoms will walk you through the specific diagnoses that have formed the core of the litigation.
Key Takeaway: Payouts are expected to range from tens of thousands to over a million dollars based on injury severity, no global settlement exists yet, and eligibility hinges on medical documentation connecting your condition to the Gardasil vaccine.
Gardasil MDL Update 2026: Where Does the Case Stand?
The Gardasil MDL entered a critical stage in 2026, with bellwether trials now scheduled and both sides deep in discovery battles. This is the most consequential phase of the litigation so far.
Discovery has involved intense battles over Merck’s internal documents. Plaintiffs’ attorneys have argued that internal Merck communications show the company’s scientists identified red flags during clinical trials that were not disclosed to the public or regulators.
Merck has challenged the admissibility of expert testimony from plaintiffs’ medical experts. Judge Conrad has had to rule on several Daubert motions, which are legal challenges to whether expert witnesses can testify. Some of those rulings have gone in Merck’s favor, others in plaintiffs’ favor.
The MDL is currently managing over 1,400 active cases. New cases continue to be filed and transferred into the MDL as more individuals come forward.
| MDL Phase | Status as of 2026 |
|---|---|
| Cases Consolidated | 1,400+ |
| Discovery Phase | Active, ongoing document battles |
| Daubert Rulings | Mixed, ongoing |
| Bellwether Trials | Scheduled for 2026 |
| Global Settlement | Not yet announced |
The outcome of the first bellwether trial is expected to be the most important single event in this litigation’s history. That verdict will tell both sides how a jury views the core science and the evidence against Merck.
What Did Merck Know? The Gardasil Lawsuit Against Merck
The lawsuit against Merck centers on one core question: what did the company know about Gardasil’s risks, and when did it know them?
Plaintiffs allege Merck used flawed clinical trial designs to hide safety signals. Specifically, they claim that Merck used aluminum-containing placebos in its clinical trials instead of true inert placebos. This allegedly made it harder to detect adverse reactions because both the vaccine and the “placebo” group experienced similar side effects.
This is a big deal. Clinical trials are supposed to compare a drug against a neutral control. If the control itself causes reactions, the comparison becomes meaningless. Plaintiffs argue this design choice was not accidental.
Merck disputes this characterization. The company maintains that Gardasil is safe and effective, that it was properly tested, and that the benefits of cervical cancer prevention far outweigh any risks. Merck has aggressively litigated these cases and has won some early legal battles on procedural grounds.
| Allegation Against Merck | Merck’s Response |
|---|---|
| Used aluminum placebos in trials | Denies improper trial design |
| Hid autoimmune adverse event data | Claims full regulatory compliance |
| Failed to warn patients adequately | States labeling met FDA standards |
| Suppressed internal safety signals | Disputes existence of hidden data |
What makes this lawsuit significant is that Merck is not a small company caught off guard. They have fought product liability claims before, including over Vioxx, which resulted in a $4.85 billion settlement. They know how to defend these cases, and they are defending this one hard.
Which Side Effects Qualify for a Gardasil Lawsuit?
The side effects that qualify for a Gardasil lawsuit are serious, chronic medical conditions that developed after vaccination, not minor reactions like soreness at the injection site.
The litigation focuses on injuries that are debilitating, long-lasting, and not adequately disclosed in the vaccine’s labeling or during the clinical trial period.
The primary qualifying conditions include:
- Postural Orthostatic Tachycardia Syndrome (POTS)
- Complex Regional Pain Syndrome (CRPS)
- Premature Ovarian Insufficiency (POI)
- Primary ovarian failure
- Autoimmune disorders (including lupus and multiple sclerosis)
- Guillain-Barre Syndrome
- Chronic fatigue syndrome (with documented post-vaccination onset)
- Fibromyalgia (post-vaccination onset with medical documentation)
Conditions that are typically not strong enough to form the basis of a standalone lawsuit include temporary injection site pain, mild fever, short-term dizziness, or headache. Those are listed on the vaccine label and are expected reactions.
| Condition | Qualifies? | Notes |
|---|---|---|
| POTS | Yes | Primary injury in many cases |
| CRPS | Yes | Strong claims with high payout potential |
| Premature Ovarian Insufficiency | Yes | Reproductive harm claims |
| Guillain-Barre Syndrome | Yes | Neurological injury |
| Lupus (post-vaccination) | Yes | Requires documentation |
| Injection site pain | No | Disclosed risk on label |
| Mild fever | No | Disclosed risk on label |
Key Takeaway: The Gardasil MDL is at a pivotal stage in 2026 with bellwether trials underway, Merck faces allegations of hiding safety data from clinical trials, and the qualifying injuries go well beyond typical vaccine side effects.
Can You File a Gardasil POTS Lawsuit?
POTS, or Postural Orthostatic Tachycardia Syndrome, is the most commonly alleged injury in the Gardasil lawsuit. Yes, you can file a Gardasil POTS lawsuit if you developed this condition after receiving the vaccine.
POTS is a nervous system disorder that causes a person’s heart rate to spike dramatically when they stand up. Symptoms include rapid heartbeat, dizziness, fainting, extreme fatigue, and in severe cases, inability to attend school or work.
For many plaintiffs, POTS developed within weeks or months of their Gardasil vaccination. The connection is not just anecdotal. Medical literature has documented potential links between aluminum adjuvants in vaccines and autonomic nervous system dysfunction, which is the underlying mechanism of POTS.
Living with POTS is not just uncomfortable. It is genuinely disabling for many patients. Young women who developed POTS after Gardasil have described going from healthy, active teenagers to being unable to stand for more than a few minutes.
| POTS Claim Detail | Information |
|---|---|
| Condition | Postural Orthostatic Tachycardia Syndrome |
| Onset Timeframe | Typically within weeks to months post-vaccination |
| Who is Affected | Predominantly young females |
| Medical Evidence | Documented in peer-reviewed literature |
| Lawsuit Status | Active, primary injury in MDL |
| Payout Potential | High, particularly for severe cases |
If you have a POTS diagnosis and you received Gardasil, your medical records and vaccination documentation form the foundation of your claim.
What Is the Gardasil CRPS Lawsuit?
CRPS, or Complex Regional Pain Syndrome, is one of the most painful conditions known to medicine. It is also one of the core injuries alleged in the Gardasil lawsuit.
CRPS typically begins in one limb and causes burning, severe pain, swelling, and skin changes. It is classified as a chronic pain condition, and many patients never fully recover. The McGill Pain Index, a widely referenced medical scale, ranks CRPS pain above that of cancer, childbirth, and amputation.
Plaintiffs in the Gardasil litigation who have CRPS tend to have some of the strongest cases in terms of injury severity. Courts and juries understand that CRPS is real, devastating, and life-altering.
The connection to Gardasil in CRPS cases often centers on the immune system response triggered by the aluminum adjuvant in the vaccine. Plaintiffs’ experts argue this response can go haywire in susceptible individuals, leading to the runaway pain signaling that defines CRPS.
| CRPS Claim Detail | Information |
|---|---|
| Condition | Complex Regional Pain Syndrome |
| Pain Level | Ranked as one of the highest on McGill Pain Index |
| Onset | Often follows vaccination or injury |
| Recovery | Many patients have permanent, lifelong symptoms |
| Gardasil Connection | Alleged immune response triggered by aluminum adjuvant |
| Lawsuit Strength | Among the strongest cases in the MDL |
Merck disputes the causal link between Gardasil and CRPS. The company argues there is no reliable scientific evidence that the vaccine caused these conditions. This scientific dispute is central to the bellwether trial testimony.
What Vaccine Injury Symptoms Are Linked to Gardasil?
The vaccine injury symptoms linked to Gardasil in the lawsuits range from neurological and cardiovascular to reproductive and autoimmune. Not all symptoms rise to the level of a legal claim, but a documented pattern matters.
The key symptoms that have appeared across thousands of reported cases and have been noted in adverse event databases like VAERS include:
- Rapid or irregular heartbeat (especially upon standing)
- Fainting or near-fainting episodes
- Chronic, unexplained fatigue
- Widespread body pain or burning sensations
- Inability to regulate body temperature
- Brain fog or cognitive difficulties
- Irregular or stopped menstrual cycles
- Premature menopause symptoms in young women
- Weakness in limbs
- Severe headaches or migraines with new onset post-vaccination
The critical issue is timing. Symptoms that appeared within days, weeks, or a few months of vaccination carry far more legal weight than symptoms that appeared years later with no documented link.
Key Takeaway: POTS and CRPS are the two most cited qualifying conditions in the Gardasil MDL, both carry strong evidentiary support, and documented symptom onset within a short post-vaccination window is essential to a successful claim.
What Are the Gardasil Lawsuit Bellwether Trials?
Bellwether trials are test cases selected to go first in front of a jury. They are not class action trials that decide everyone’s outcome. Instead, they give both sides a real-world look at how a jury responds to the evidence.
In the Gardasil MDL, Judge Conrad ordered the selection of several bellwether cases to proceed to trial in 2026. These cases were chosen because they represent the types of claims most common across the full docket.
Why does this matter to you if you are a plaintiff? Because a bellwether verdict is the single most powerful event in mass tort settlement negotiations.
If a jury awards a plaintiff $5 million in the first Gardasil bellwether trial, Merck will know it faces enormous exposure across 1,400 or more cases. That number puts immediate pressure on the company to settle all remaining cases rather than risk similar verdicts. The opposite is also true: a defense verdict gives Merck leverage to push back on settlement demands.
| Bellwether Function | Details |
|---|---|
| Purpose | Test jury response to core evidence |
| Selected Cases | Chosen to represent the typical MDL plaintiff |
| 2026 Status | Scheduled, ongoing |
| Impact on Settlements | Major. Verdicts shape global settlement offers. |
| Prior MDL Example | Roundup first bellwether: $289M verdict (later reduced) |
The pharmaceutical industry watches these trials closely. Attorneys representing future Gardasil plaintiffs watch them even more closely.
How Much Compensation Can You Get From a Gardasil Lawsuit?
The compensation available from a Gardasil lawsuit depends on what you can prove and how severe your injury is. There is no fixed amount.
Compensation in pharmaceutical mass tort cases typically covers several categories of damages:
- Medical expenses: Past and future costs of treating your injury
- Lost income: Wages lost due to your inability to work
- Pain and suffering: Non-economic damages for chronic pain and disability
- Loss of quality of life: Compensation for inability to participate in activities you previously enjoyed
- Punitive damages: Potentially available if Merck’s conduct is found to be egregious
For young plaintiffs who were injured as teenagers and now face lifelong conditions, the lost income calculation alone can be substantial. A 16-year-old who develops disabling POTS and cannot pursue a career has decades of economic harm to claim.
| Damage Type | What It Covers |
|---|---|
| Medical Expenses | All past and future treatment costs |
| Lost Wages | Income lost due to inability to work |
| Pain and Suffering | Physical and emotional suffering |
| Loss of Life Quality | Inability to enjoy normal activities |
| Punitive Damages | Punishment for egregious corporate conduct |
Punitive damages are not guaranteed. They require showing that Merck acted with particular recklessness or deliberate disregard for safety. Given the allegations about trial design and internal data, some plaintiffs’ attorneys believe this is achievable.
How to File a Gardasil Lawsuit in 2026
Filing a Gardasil lawsuit in 2026 starts with gathering your documentation and connecting with an attorney who specializes in pharmaceutical mass tort cases.
The process is not complicated, but it has specific steps that must be followed in the right order.
Step 1: Gather your records.
Collect your vaccination records, any medical records showing your diagnosis, and documentation of how the condition has affected your work, school, and daily life.
Step 2: Contact a mass tort attorney.
You need an attorney who is already working on Gardasil cases or has experience with pharmaceutical MDL litigation. Cases inside the MDL require coordination with the established structure of the litigation.
Step 3: Case evaluation.
Your attorney will review your records and assess whether your case meets the criteria being accepted into the MDL or for individual filing.
Step 4: Filing the complaint.
Your attorney files a complaint against Merck. If your case qualifies for the MDL, it is transferred to the Western District of North Carolina.
Step 5: Discovery and proceedings.
Your case joins the MDL discovery process. You may be asked to provide additional medical records, sit for a deposition, or complete a plaintiff fact sheet.
| Step | Action Required |
|---|---|
| 1 | Gather vaccination and medical records |
| 2 | Contact a pharmaceutical mass tort attorney |
| 3 | Case evaluation and qualifying assessment |
| 4 | File complaint, transfer to MDL |
| 5 | Discovery, depositions, fact sheet completion |
The most important thing you can do right now is not wait. Deadlines in mass tort litigation are real, and missing them can eliminate your right to recover.
How to Submit a Gardasil HPV Vaccine Injury Claim
Submitting a Gardasil HPV vaccine injury claim is separate from filing through the court system if your injury occurred under specific circumstances. There are actually two distinct tracks available to some plaintiffs.
Track 1: MDL Lawsuit Against Merck
This is the standard civil litigation route. You file a personal injury lawsuit alleging product liability, failure to warn, and negligence against Merck. This track has no cap on damages and is the primary route for most Gardasil plaintiffs.
Track 2: National Vaccine Injury Compensation Program (VICP)
Congress created this federal program to handle vaccine injury claims for certain covered vaccines. Gardasil is one of them. The VICP operates through a specialized court often called the “Vaccine Court.”
The tradeoff is significant. VICP payouts are faster but capped. You cannot sue Merck directly in civil court for the same injury if you have received a VICP award.
| Claim Track | Pros | Cons |
|---|---|---|
| MDL Civil Lawsuit | No cap on damages, full jury trial rights | Slower, more uncertain |
| VICP (Vaccine Court) | Faster resolution, government-backed | Capped payouts, limits civil lawsuit rights |
Many attorneys advise clients to pursue the MDL route because the potential compensation is significantly higher. But your specific situation, timeline, and injury type may affect which track is right for you.
Key Takeaway: Compensation in the Gardasil lawsuit can cover medical bills, lost income, and suffering, the filing process involves joining the existing MDL, and plaintiffs have two potential tracks: civil litigation against Merck or the federal VICP program.
What Is the Gardasil Lawsuit Filing Deadline?
The Gardasil lawsuit filing deadline depends on your state’s statute of limitations and when you discovered your injury was linked to the vaccine.
Statutes of limitations for personal injury cases vary by state, typically ranging from 2 to 6 years from the date of injury or discovery. The discovery rule is especially important here. If you were vaccinated in 2012 but only learned in 2023 that your POTS diagnosis was linked to Gardasil, your clock may have started in 2023, not 2012.
For VICP claims, the deadline is 3 years from the first symptom of the vaccine injury. This is a firm deadline with limited exceptions.
| Filing Deadline Type | Timeframe | Notes |
|---|---|---|
| State Civil Lawsuit (average) | 2 to 6 years | Starts at injury or discovery |
| Discovery Rule Exception | Varies | Clock starts when link is discovered |
| VICP (Vaccine Court) | 3 years from first symptom | Limited exceptions available |
| MDL Transfer | No separate deadline | Must file civil case first |
Do not assume you are outside the deadline without talking to an attorney first. The discovery rule has saved many plaintiffs who thought they had missed their window.
Bold reminder: In mass tort cases, waiting often means losing. As cases near trial, attorneys become more selective. Acting in 2026 puts you in a far stronger position than waiting.
Gardasil Lawsuit Latest News 2026
The biggest Gardasil lawsuit news of 2026 centers on bellwether trial preparation, new scientific evidence entering the record, and growing congressional attention to vaccine safety transparency.
Bellwether trials are now scheduled and both sides have completed or are completing their expert witness disclosures. Plaintiffs’ experts are expected to present testimony on the mechanism by which aluminum adjuvants may trigger autoimmune dysfunction. Merck’s experts will challenge that science at every step.
A significant development involves internal Merck documents obtained through discovery. Plaintiffs’ attorneys have argued these documents show internal safety committee discussions that were not fully reflected in published clinical trial data. Merck has fought to keep many of these documents sealed, but courts have ordered partial disclosure.
New plaintiffs continue to join the litigation at a consistent rate. The MDL docket has grown steadily, which increases the pressure on both sides to reach resolution before years more of expensive litigation.
On the legislative side, some members of Congress have expressed renewed interest in requiring more transparent reporting of adverse events for vaccines, specifically citing the Gardasil situation as a driver of that interest.
| 2026 Development | Details |
|---|---|
| Bellwether Trials | Scheduled and actively moving forward |
| Internal Merck Documents | Partially disclosed, subject of ongoing legal battles |
| New Case Filings | Continuing to grow the MDL docket |
| Congressional Interest | Renewed attention to vaccine transparency |
| Scientific Testimony | Aluminum adjuvant mechanism under courtroom scrutiny |
The litigation is at a point where 2026 could be the year that defines the ultimate outcome for everyone involved.
Frequently Asked Questions
How much money will I get from a Gardasil lawsuit?
There is no guaranteed amount, but projected payouts range from $50,000 to over $1 million depending on injury severity.
Plaintiffs with permanent, disabling conditions like CRPS or severe POTS are expected to receive the highest compensation.
No global settlement has been announced yet, so final amounts depend on bellwether trial outcomes and any deal Merck negotiates.
Is the Gardasil lawsuit a class action?
No, the Gardasil lawsuit is not a class action.
It is a mass tort multidistrict litigation, meaning each plaintiff has their own individual case with individual damages.
Cases are coordinated together in one federal court to make pretrial proceedings more efficient, but each plaintiff’s outcome is determined separately.
What injuries qualify for the Gardasil lawsuit?
The primary qualifying injuries are POTS, CRPS, premature ovarian insufficiency, Guillain-Barre Syndrome, and autoimmune conditions that developed after vaccination.
Minor reactions listed on the vaccine label, like injection site pain or short-term fever, do not qualify as the basis for a lawsuit.
Medical documentation proving both your diagnosis and a timeline connecting it to your vaccination is required.
What is the current status of the Gardasil MDL in 2026?
The Gardasil MDL has more than 1,400 active cases and is in the bellwether trial phase as of 2026.
Both sides are engaged in expert witness battles and ongoing discovery disputes over Merck’s internal documents.
No global settlement has been reached, but the results of the first bellwether trials will likely determine whether settlement negotiations accelerate.
How long does a Gardasil lawsuit take to settle?
Mass tort pharmaceutical cases typically take 5 to 10 years from initial filing to global settlement resolution.
The Gardasil MDL began in earnest around 2022, which means a global resolution could come somewhere between 2026 and 2030 based on comparable litigation timelines.
Plaintiffs selected as early bellwether trial cases may see resolution sooner than those deeper in the MDL queue.
What This Means for You Right Now
The Gardasil lawsuit is moving fast in 2026. With bellwether trials underway and Merck’s internal documents now entering the record, this is the year the trajectory of the litigation becomes clear.
If you or someone you know received Gardasil and developed a serious health condition, the window to file is open but it will not stay open forever. Your medical records and vaccination history are your starting point.
Start by pulling those records together. Talk to an attorney who handles pharmaceutical mass tort cases. The people who act now are the ones who preserve their legal rights.
